Toshihiko Okumura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Toshihiko Okumura has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Kenta Ito
Department of General Pediatrics, Aichi Children's Health and Medical Center, Aichi, Japan
3 shared publications - Akari Nagai
Department of Pediatrics Takatsuki General Hospital Osaka Japan
1 shared publication - Daigo Kato
Department of Allergy and Rheumatology, Chiba Children’s Hospital , Chiba-shi, Chiba
1 shared publication Eiki Ogawa
Department of General Pediatrics Aichi Children's Health and Medical Center Obu Aichi Japan
1 shared publication- Eiki Ogawa
Department of General Pediatrics, Aichi Children's Health and Medical Center, Aichi, Japan
1 shared publication Haruki Mizutani
Department of Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Aichi, Japan
1 shared publication
Latest Publications
- 16 June 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (8) , 103017
Prolonged cholestasis following severe neonatal echovirus 11 (genotype D5, new lineage 1) infection diagnosed by serum detection
- 16 June 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (8) , 103017
Prolonged cholestasis following severe neonatal echovirus 11 (genotype D5, new lineage 1) infection diagnosed by serum detection
- 10 February 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (3) , 102927
Evaluation of an in-house rapid antimicrobial susceptibility testing (RAST) using the direct disk-diffusion method for gram-negative bacilli from positive blood cultures in a Japanese tertiary hospital
- 10 February 2026
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 32 (3) , 102927
Evaluation of an in-house rapid antimicrobial susceptibility testing (RAST) using the direct disk-diffusion method for gram-negative bacilli from positive blood cultures in a Japanese tertiary hospital
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70410
Descriptive Epidemiology of Aerococcus urinae Isolated From Urine Cultures in a Pediatric Hospital: A Case Series
Background: Aerococcus urinae is a potential causative pathogen of urinary tract infections in pediatric patients with underlying nephrological or urinary tract disorders. However, the need for targeted antimicrobial therapy remains controversial. Herein, we evaluated pediatric patients in whom A. urinae was identified in urine cultures and compared the clinical outcomes between those who received antimicrobial therapy and those managed with observation alone. Methods: Urine cultures submitted from 2018 to 2023 were retrospectively reviewed. Cases were included if A. urinae was cultured at ≥ 10 4 colony‐forming units (CFU)/mL in the presence of pyuria. Results: Twenty‐six patients met the inclusion criteria; all had preexisting nephrological or urinary tract disorders. A. urinae was isolated as a monoclonal species in only two cases. Thirteen patients (50%) received antimicrobial therapy, most commonly for cystitis, while 13 (50%) were managed conservatively without antimicrobials, achieving spontaneous resolution without relapse. Comparative analysis revealed that myelomeningocele and nitrite positivity were significantly more frequent in the observation group ( p = 0.021 and p = 0.009, respectively). Co‐infection with other bacterial species was frequently observed in cases where A. urinae was isolated; however, whether these co‐isolated organisms were the primary pathogens remains unclear, along with guidance on treatment decisions. Conclusions: Given that approximately half of the cases involving multiple organisms, including A. urinae , were resolved without antimicrobial intervention, it is crucial to reassess the clinical significance of A. urinae and its potential for contaminating such cultures. Treatment decisions should be individualized by considering anatomical risk factors and the overall clinical context.
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70410
Descriptive Epidemiology of Aerococcus urinae Isolated From Urine Cultures in a Pediatric Hospital: A Case Series
Background: Aerococcus urinae is a potential causative pathogen of urinary tract infections in pediatric patients with underlying nephrological or urinary tract disorders. However, the need for targeted antimicrobial therapy remains controversial. Herein, we evaluated pediatric patients in whom A. urinae was identified in urine cultures and compared the clinical outcomes between those who received antimicrobial therapy and those managed with observation alone. Methods: Urine cultures submitted from 2018 to 2023 were retrospectively reviewed. Cases were included if A. urinae was cultured at ≥ 10 4 colony‐forming units (CFU)/mL in the presence of pyuria. Results: Twenty‐six patients met the inclusion criteria; all had preexisting nephrological or urinary tract disorders. A. urinae was isolated as a monoclonal species in only two cases. Thirteen patients (50%) received antimicrobial therapy, most commonly for cystitis, while 13 (50%) were managed conservatively without antimicrobials, achieving spontaneous resolution without relapse. Comparative analysis revealed that myelomeningocele and nitrite positivity were significantly more frequent in the observation group ( p = 0.021 and p = 0.009, respectively). Co‐infection with other bacterial species was frequently observed in cases where A. urinae was isolated; however, whether these co‐isolated organisms were the primary pathogens remains unclear, along with guidance on treatment decisions. Conclusions: Given that approximately half of the cases involving multiple organisms, including A. urinae , were resolved without antimicrobial intervention, it is crucial to reassess the clinical significance of A. urinae and its potential for contaminating such cultures. Treatment decisions should be individualized by considering anatomical risk factors and the overall clinical context.
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70371
Early‐infant Streptococcus gallolyticus sepsis linked to congenital splenic dysfunction: A three‐case series
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1) , e70371
Early‐infant Streptococcus gallolyticus sepsis linked to congenital splenic dysfunction: A three‐case series